Ascendis Pharma A/S | 6-K:外国发行人报告
Ascendis Pharma A/S | 144:拟议出售证券
Ascendis Pharma A/S | 144:拟议出售证券
Ascendis Pharma A/S | 144:拟议出售证券
Ascendis Pharma A/S | 144:拟议出售证券
Ascendis Pharma A/S | 144:拟议出售证券
Ascendis Pharma A/S | 144:拟议出售证券
Ascendis Pharma A/S | 144:拟议出售证券
Ascendis Pharma A/S | 144:拟议出售证券
Ascendis Pharma A/S | 144:拟议出售证券
Ascendis Pharma A/S | SC 13G/A:超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(16.1%),Peter Kolchinsky(16.1%)等
Ascendis Pharma A/S | 6-K:外国发行人报告(业绩相关)
Ascendis Pharma A/S | 6-K:外国发行人报告(业绩相关)
Ascendis Pharma A/S | SC 13G/A:超过5%持股股东披露文件(修正)-Janus Henderson Group plc(7.0%)
Ascendis Pharma A/S | SC 13G/A:超过5%持股股东披露文件(修正)-T. Rowe Price Investment Management, Inc.(2.9%)
Ascendis Pharma A/S | SC 13G/A:超过5%持股股东披露文件(修正)-Avoro Capital Advisors LLC(8.2%),Behzad Aghazadeh(8.2%)
Ascendis Pharma A/S | 6-K:外国发行人报告
Ascendis Pharma A/S | SC 13G/A:超过5%持股股东披露文件(修正)-Artisan Partners Limited Partnership(7.3%),Artisan Investments GP LLC(7.3%)等
Ascendis Pharma A/S | SC 13G/A:超过5%持股股东披露文件(修正)-Wellington Management Group LLP(2.21%),Wellington Group Holdings LLP(2.21%)等
Ascendis Pharma A/S | 6-K:外国发行人报告